Found: 112
Select item for more details and to access through your institution.
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3139, doi. 10.1007/s00432-022-04215-7
- By:
- Publication type:
- Article
Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 1, p. 82, doi. 10.1093/jjco/hyx153
- By:
- Publication type:
- Article
Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 618, doi. 10.1093/jjco/hyx045
- By:
- Publication type:
- Article
A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 4, p. 298, doi. 10.1093/jjco/hyx008
- By:
- Publication type:
- Article
Phase II study of amrubicin at a dose of 45mg/m² in patients with previously treated small-cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 10, p. 941, doi. 10.1093/jjco/hyv107
- By:
- Publication type:
- Article
Adjuvant Chemotherapy in Patients with Completely Resected Small Cell Lung Cancer: A Retrospective Analysis of 26 Consecutive Cases.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 9, p. 835, doi. 10.1093/jjco/hyu092
- By:
- Publication type:
- Article
Secondary Osteosarcoma Developing 10 Years after Chemoradiotherapy for Non-small-cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 2, p. 191, doi. 10.1093/jjco/hyt192
- By:
- Publication type:
- Article
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
- Published in:
- International Journal of Cancer, 1999, v. 80, n. 5, p. 773, doi. 10.1002/(SICI)1097-0215(19990301)80:5<773::AID-IJC23>3.0.CO;2-E
- By:
- Publication type:
- Article
Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.
- Published in:
- BMC Research Notes, 2015, v. 8, p. 1, doi. 10.1186/s13104-015-1762-z
- By:
- Publication type:
- Article
Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion.
- Published in:
- Internal Medicine, 2022, v. 61, n. 9, p. 1393, doi. 10.2169/internalmedicine.8195-21
- By:
- Publication type:
- Article
Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2022, v. 61, n. 8, p. 1211, doi. 10.2169/internalmedicine.7300-21
- By:
- Publication type:
- Article
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 3, p. 259, doi. 10.1111/ajco.12485
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF<sup>V600</sup> mutation-positive solid tumors: a phase 1 study.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 259, doi. 10.1007/s10637-017-0502-8
- By:
- Publication type:
- Article
Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 207, doi. 10.1007/s10637-016-0411-2
- By:
- Publication type:
- Article
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 217, doi. 10.1007/s10637-017-0435-2
- By:
- Publication type:
- Article
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 66, doi. 10.1007/s10637-015-0300-0
- By:
- Publication type:
- Article
Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 4, p. 881, doi. 10.1007/s10637-015-0243-5
- By:
- Publication type:
- Article
Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 632, doi. 10.1007/s10637-015-0227-5
- By:
- Publication type:
- Article
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 641, doi. 10.1007/s10637-015-0229-3
- By:
- Publication type:
- Article
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z
- By:
- Publication type:
- Article
Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 5, p. 385, doi. 10.1016/j.cllc.2015.03.008
- By:
- Publication type:
- Article
Clinicopathological Features in Young Patients Treated for Small-Cell Lung Cancer: Significance of Immunohistological and Molecular Analyses.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 3, p. 244, doi. 10.1016/j.cllc.2013.06.012
- By:
- Publication type:
- Article
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2846, doi. 10.3390/cancers14122846
- By:
- Publication type:
- Article
Perspectives of non-specialists on the potential to serve as ethics committee members.
- Published in:
- Journal of International Medical Research, 2019, v. 47, n. 5, p. 1868, doi. 10.1177/0300060518823941
- By:
- Publication type:
- Article
A case of successful treatment with eltrombopag for severe immune-related thrombocytopenia induced by atezolizumab: Case report.
- Published in:
- Journal of Medical Investigation, 2023, v. 70, n. 3/4, p. 516, doi. 10.2152/jmi.70.516
- By:
- Publication type:
- Article
Academic investigators' interest in promoting specified clinical trials: Questionnaire survey before and after implementation of the Clinical Trial Act.
- Published in:
- Journal of Medical Investigation, 2021, v. 68, n. 1/2, p. 71, doi. 10.2152/jmi.68.71
- By:
- Publication type:
- Article
Erratum to: Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 677, doi. 10.1007/s10637-012-9860-4
- By:
- Publication type:
- Article
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1548, doi. 10.1007/s10637-011-9715-4
- By:
- Publication type:
- Article
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 4, p. 717, doi. 10.1038/mt.2015.10
- By:
- Publication type:
- Article
Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7418, doi. 10.1002/cam4.3385
- By:
- Publication type:
- Article
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 6, p. 575, doi. 10.1001/jamaneurol.2022.0901
- By:
- Publication type:
- Article
Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity.
- Published in:
- Cancer Science, 2007, v. 98, n. 9, p. 1408, doi. 10.1111/j.1349-7006.2007.00532.x
- By:
- Publication type:
- Article
Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer.
- Published in:
- Cancer Science, 2004, v. 95, n. 8, p. 691, doi. 10.1111/j.1349-7006.2004.tb03331.x
- By:
- Publication type:
- Article
Multifunctional interleukin-1β promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules.
- Published in:
- Cancer Science, 2003, v. 94, n. 3, p. 244, doi. 10.1111/j.1349-7006.2003.tb01428.x
- By:
- Publication type:
- Article
A New Quinoline Derivative MS-209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P-glycoprotein-expressing Human Small Cell Lung Cancer Cells.
- Published in:
- Cancer Science, 2001, v. 92, n. 7, p. 785, doi. 10.1111/j.1349-7006.2001.tb01162.x
- By:
- Publication type:
- Article
Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term follow-up results.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 6, n. 1, p. 56, doi. 10.3892/mco.2016.1076
- By:
- Publication type:
- Article
Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice.
- Published in:
- International Journal of Cancer, 2001, v. 94, n. 1, p. 16, doi. 10.1002/ijc.1445
- By:
- Publication type:
- Article
Combined therapy with anti-p-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in nk cell-depleted scid mice.
- Published in:
- International Journal of Cancer, 1999, v. 82, n. 1, p. 105, doi. 10.1002/(SICI)1097-0215(19990702)82:1<105::AID-IJC18>3.0.CO;2-C
- By:
- Publication type:
- Article
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12451, doi. 10.1038/ncomms12451
- By:
- Publication type:
- Article
Short Hydration in Chemotherapy Containing Cisplatin (≥75 mg/m2) for Patients with Lung Cancer: A Prospective Study.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 11, p. 1105, doi. 10.1093/jjco/hyt122
- By:
- Publication type:
- Article
Successful EGFR-TKI Rechallenge of Leptomeningeal Carcinomatosis after Gefitinib-induced Interstitial Lung Disease.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 4, p. 422, doi. 10.1093/jjco/hyt012
- By:
- Publication type:
- Article
Gender Difference in Hematological Toxicity Among Lung Cancer Patients Receiving Amrubicin Monotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 12, p. 1187, doi. 10.1093/jjco/hys170
- By:
- Publication type:
- Article